Life Sciences Strategy

As an economic hub, the Basel region can only benefit from systematical expansion of the life sciences industry’s already extraordinary potential for creating added value. Basic influential factors must consistently be questioned anew and re-optimized – all the more so given the steady, ongoing rise in global competition in the life sciences industry, replete with added value potential.


This forms the basis for collaboration between the Basel Chamber of Commerce and its initiative partners in regularly conceiving new joint life sciences strategies (previous versions: 2005, 2008, and 2011). The key points of each strategy are laid out in an input paper by the Life Sciences Commission of the Chamber of Commerce, whilst the strategy platform is discussed at Bad Schauenburg (Bad Schauenburg Conference) with experts from politics, administration, academia, health care, and business in order to agree on a common line of approach for the life sciences region of Basel, involving goal-setting and the definition of required fields of action. Conference results are subsequently incorporated into an action plan, which, in conjunction with set goals, forms the Life Sciences Strategy. Any given strategy remains applicable until it is revised and replaced at the following Bad Schauenburg Conference with a new, farther-reaching strategy. Each strategy period generally lasts 3 years.


The current Life Sciences Strategy for 2018-2021 pursues the following main objectives:

  • The Basel region is a global leader in the life sciences sector.
  • The life sciences industry of the Basel region is a competitive and attractive area of business; it has a great innovative force and continues to invest locally.
  • The Basel region features top players in the life sciences value-added chain (universities, research institutes, company headquarters, research and development, production, hospitals, relevant service providers and suppliers).
  • The Basel region is the top location for start-ups in the field of life sciences.
  • Precision Medicine is established in the Basel region. The Life Sciences Strategy supports the collaboration of universities, health care service providers and suppliers, industry and the hospitals in coordination with the existing initiatives.

Read more: Life Sciences-Strategie 2018-2021